Shares of Biotech MicroCap Rip on Licensing Talks
2024年6月14日 - 12:40AM
AllPennyStocks.com
This firm develops therapeutic products using cell and tissue
protocols, primarily involving adult stem cells. And news of a
potential licensing agreement is sending shares soaring in
morning...
To read the full story on AllPennyStocks.com, click
here.
BioRestorative Therapies (NASDAQ:BRTX)
過去 株価チャート
から 5 2024 まで 6 2024
BioRestorative Therapies (NASDAQ:BRTX)
過去 株価チャート
から 6 2023 まで 6 2024
